TIVC
Tivic Health Systems, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.26
−10.46%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | (156.0K) | 382.0K | 780.0K | 1.2M | 1.8M |
| Cost of Revenue | 649.0K | 5.0K | 778.0K | 889.0K | 1.5M |
| Gross Profit | (805.0K) | (5.0K) | 2.0K | 287.0K | 299.0K |
| Operating Expenses | |||||
| R&D Expense | 6.7M | 3.1M | 1.3M | 1.7M | 1.7M |
| SG&A Expense | 9.7M | 5.6M | 4.3M | 6.9M | 8.7M |
| General & Admin Expense | 6.6M | 4.8M | 3.2M | 4.8M | 5.9M |
| Selling & Marketing Expense | (605.0K) | 800.0K | 1.2M | 2.1M | 2.8M |
| Other Expenses | (701.0K) | (805.0K) | — | — | — |
| Total Operating Expenses | 15.7M | 7.9M | 5.7M | 8.5M | 10.4M |
| Cost and Expenses | 16.4M | 7.9M | 6.4M | 9.4M | 11.9M |
| Operating Income (EBIT) | (16.5M) | (7.9M) | (5.7M) | (8.2M) | (10.1M) |
| Non-Operating | |||||
| Interest Income | 27.0K | 23.0K | 6.0K | 1.0K | 2.0K |
| Interest Expense | 1.3M | 146.0K | — | — | — |
| Net Interest Income | (1.3M) | (123.0K) | 6.0K | 1.0K | 2.0K |
| Other Non-Op Income/Expense | (1.3M) | (95.0K) | 6.0K | 999.00 | 2.0K |
| Non-Operating Income (excl Interest) | 62.0K | (51.0K) | — | — | — |
| EBT (Pre-Tax Income) | (17.8M) | (8.0M) | (5.7M) | (8.2M) | (10.1M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (18.8M) | (8.9M) | (5.7M) | (8.2M) | (10.1M) |
| Earnings from Cont. Ops | (17.8M) | (8.0M) | (5.7M) | (8.2M) | (10.1M) |
| Earnings from Discont. Ops | (46.0K) | (885.0K) | — | — | — |
| Bottom Line Net Income | (18.7M) | (8.9M) | (5.7M) | (8.2M) | (10.1M) |
| Per Share | |||||
| Basic EPS | ($7.20) | ($7.84) | ($19.67) | ($176.72) | ($104.37) |
| Diluted EPS | ($7.20) | ($7.84) | ($19.67) | ($176.72) | ($104.37) |
| Revenue Per Share | ($0.05) | $1.33 | $0.00 | $25.21 | $19.02 |
| Shares | |||||
| Basic Shares Outstanding | 3.4M | 287370 | 287.4M | 46650 | 96729 |
| Diluted Shares Outstanding | 3.4M | 287370 | 287.4M | 46650 | 96730 |
| Profitability Metrics | |||||
| EBITDA | (16.4M) | (7.8M) | (5.3M) | (8.1M) | (9.9M) |
| D&A | 184.0K | 5.0K | 352.0K | 182.0K | 174.0K |
| EBIT | (16.6M) | (7.8M) | (5.7M) | (8.2M) | (10.1M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026